Evaluation of Knowledge and Attitudes About The Traditional and Complementary Medicine Practices of the Patients with Neuropatic Pain Who Applied to the Physıcal Medicine and Rehabilitation Clinic

Year 2021, Volume: 2 Issue: 3, 175 - 183, 20.12.2021

Dilek Özge Zincir Erçin , Aysun Özlü

https://doi.org/10.53811/ijtcmr.1022341

Abstract

Objective: To evaluate the frequency of traditional and complementary medicine (TCM) use, the variety of applications, the sociodemographic and clinical characteristics of patients with neuropathic pain, and their knowledge and attitudes about TCM practices.

Material and Methods: A total of 250 patients with neuropathic pain were included in this, cross-sectional study. The patients were divided into two groups: medication only (group 1, n=119) and medication with TCM practices (group 2, n=131). Questionnaires were completed by the patients in face-to-face interviews by a blinded physician.

Results: The mean age of the patients in group 2 (50.68±16.39) was found to be higher than in group 1 (p=0.043). In terms of chronic diseases, hypertension, cardiovascular diseases, and other diseases were found to be more common in group 2 than in group 1 (p<0.05). The number of patients with duration of neuropathic pain more than 5 years, the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale and the Neuropathic Pain 4 (DN4) scale scores were found to be higher in group 2 than in group 1 (p<0.05). At least one TCM is known by %78.6 of group 2 and 61.3% of group 1 (p=0.003). The three most commonly used TCM practice in group 2 were wet cupping/cupping therapy (24%), leeches (22.8%), and acupuncture (11.6%).

Conclusion: It was determined that the mean age of patients who used medication with TCM practices together for the treatment of neuropathic pain was higher, neuropathic pain severity was higher, and neuropathic pain duration was longer than patients who used medication only for the treatment of neuropathic pain.

Keywords

Neuropathic, Pain, Traditional, Complementary, Medicine

Supporting Institution

-

Project Number

-

Thanks

-

References

• Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, Treede RD. A new definition of neuropathic pain. Pain. 2011;152(10) :2204-2205.
• Jensen, T. S., Gottrup, H., Sindrup, S. H., & Bach, F. W. (2001). The clinical picture of neuropathic pain. European journal of pharmacology, 429(1-3), 1-11.
• Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology. 1999; 52(3), 617-617.
• Carter GT, Galer BS. Advances in the management of neuropathic pain. Physical medicine and rehabilitation clinics of North America. 2001; 12:447–459
• Bowsher D. Neurogenic pain syndromes and their management. British medical bulletin. 1991;47:644–666.
• Cruccu G, Truini A. A review of neuropathic pain: from guidelines to clinical practice. Pain and therapy. 2017;6(S1):35–42
• Bouhassira D, Attal N. The multiple challenges of neuropathic pain. Neuroscience letters. 2019;702, 6-10.
• Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73
• Çağlayan HZB, Ataoğlu EE, Kibaroğlu S. The Assesment of Efficacy of Traditional and Complementary Medicine Practices in Neurology. Turk Noroloji Dergisi. 2018;24(2), 111.
• Halat KM, Dennehy CE. Botanicals and dietary supplements in diabetic peripheral neuropathy. J Am Board Fam Pract. 2003;16:47 – 57.
• Dalton K, Dalton MJ. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76:8– 11.
• Nural N, Çakmak S. Kronik Hastalığı Olan Bireylerin Tamamlayıcı ve Alternatif Tedavileri Kullanma Durumu. Geleneksel ve Tamamlayıcı Tıp Dergisi. 2018;1(1), 1-9.
• Kılıç KN, Soylar P. Geleneksel ve Tamamlayıcı Tıp Uygulamalarına Başvuran Bireylerin Tutumları, Başvurma Nedenleri ve Memnuniyet Düzeylerinin İncelenmesi. Turkiye Klinikleri Journal of Biostatistics. 2019;11(3).
• Galantino ML, Eke-Okoro ST, Findley TW, Condoluci D. Use of noninvasive electroacupuncture for the treatment of HIV-related peripheral neuropathy: a pilot study. J Altern Complement Med.1999; 5:135–42.
• Furnham A, Bhagrath RA. Comparison of health beliefs and behaviours of clients of orthodox and complementary medicine. British Journal of Clinical Psychology. 1993; 32(Pt 2): 237–247.
• Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990– 1997: results of a followup national survey. JAMA 1998;280:1569 – 75.
• Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia IB, Dhingra SS, McKnight-Eily LR, Safran MA. Mental illness surveillance among adults in the United States. MMWR Surveil Summ 2011;60(3):1e29.
• Gündüzoğlu NÇ, Karadakovan A Yaşlılarda ağrı yönetimi Geriatr Neuropsychiatr 2011; 2(2-3):41-8; Aslan FE, Uzun Ö Yaşlılarda Ağrı Aslan FE, editör Ağrı Doğası ve Kontrolü 2 Baskı Ankara: Akademisyen Tıp Kitabevi; 2014:357-74.
• Çilingir D, Bulut E. Yaşlı Bireylerde Ağrıya Yaklaşım. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi. 2017;20(2).
• Donofrio PD, Albers JW. Polyneuropathy: classification by nerve conduction studies and electromyography. Muscle Nerve. 1990;13: 889– 903.
• Molenaar DS, Vermeulen M, de Visser M, De Haan R. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies. Neurology. 1999;52:151– 6.
• Aydin S, Bozkaya AO, Mazicioglu M, Gemalmaz A, Özçakir A, Öztürk A. What influences herbal medicine use? Prevalence and related factors. Turk J Med Sci. 2008;38(5):455e63.
• Tan M, Uzun O, Akcay F. Trends in complementary and alternative medicine in eastern Turkey. J Altern Complement Med. 2004;10(5):861e5.
• Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Alternative medicine in the United States Prevalence, costs and patterns of use. N Engl J Med. 1993;328:246– 52.
• Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States CA. Cancer J Clin. 1992;42: 181–91.
• Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic diseases Use in brain tumor patients. Neurology. 1999; 52:617– 22.
• Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology.1999;52:626– 9.
• Wasner M, Klier H, Borasio GD. The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;11: 151–4.
• Von Peter S, Ting W, Scrivani S, Korkin E, Okvat H, Gross M, Balmaceda C. Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia. 2002;22:395– 400.
• Lee FH, Raja SN. Complementary and alternative medicine in chronic pain. Pain. 2011;152(1), 28-30.
• Brunelli B, Gorson KC. The use of complementary and alternative medicines by patients with peripheral neuropathy. J Neurol Sci. 2004;218:59–66.
• Cheung CK, Wyman JF, Halcon LL. Use of complementary and alternative therapies in community-dwelling older adults. J Altern Complement Med. 2007;13:997 1006.
• Rosenberg EI, Genao I, Chen I, Mechaber AJ, Wood JA, Faselis CJ, Cykert S. Complementary and alternative medicine use by primary care patients with chronic pain. Pain Med. 2008;9:1065–72.
• Ndao-Brumblay SK, Green CR. Predictors of complementary and alternative medicine use in chronic pain patients. Pain Med. 2010;11:16–24.
• Altun B, Arıcı M, Nergizoğlu G, Derici U, Karatan O, Turgan C, Cağlar S. For the Turkish Society of hypertension and renal diseases prevalence, awareness, treatment and control of hypertension in Turkey (The PatenT study) in 2003. J Hypertens. 2005; 23:1817-23 36.Öngen Z. Çözümü zor bir toplumsal sorun: hipertansiyon. Klinik Gelişim. 2005;18(2):4-7.
• Toprak D, Demir S. Treatment choices of hypertensive patients in Turkey. Behav Med.2007; 33(1):5-10.
• Binder A, Baron R. The pharmacological therapy of chronic neuropathic pain. Deutsches Ärzteblatt International. 2016;113(37), 616.
• Finnerup NB, Sindrup SH. Jensen TS The evidence for phar-macological treatment of neuropathic pain. Pain. 2010;150(3): 573–581.
• Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Jensen TS. Neuro-path-ic pain: an updated grading system for research and clinicalpractice. Pain. 2016;157(8): 1599–1606.
• Complementary, Alternative, or Integrative Health: What’s In a Name? https://nccih nihgov/health/integrative-health
• Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012 National Center for Health Statistics; Hyattsville, MD: 2015 National health statistics reports; no 79.
• Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. Resmi Gazete. 27.10.2014. https://www.resmigazete.gov.tr/eskiler/2014/10/20141027.pdf